Analystreport

BioXcel Therapeutics Inc (NASDAQ: BTAI) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

BioXcel Therapeutics, Inc.  (BTAI) 
Last bioxcel therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report